Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Oramed granted approval for Phase IIA diabetic study
This Phase IIA study is designed to evaluate the safety and efficacy of Oramed’s oral insulin capsule on Type II diabetic volunteers. This study is slated to begin
This Phase IIA study is designed to evaluate the safety and efficacy of Oramed’s oral insulin capsule on Type II diabetic volunteers. This study is slated to begin
Under the terms of the agreement, Corgenix has the exclusive rights outside of Japan to further develop the serum amyloid technology, including adapting to research and clinical diagnostic
The European Group for the Study of Insulin Resistance (EGIR) has compiled large numbers of biological samples from studies conducted at 19 clinical research centers across Europe as
The claims of the newly issued patent cover a broad range of methods for the use of a specific sequence of small interfering RNAs (siRNA), including bevasiranib, to
The two vitrification products that Vitrolife has obtained approval for are RapidVit Cleave and RapidWarm Cleave. Products for vitrification involve considerable technological progress and open up new opportunities
The Coolrail linear ablation pen is designed to facilitate the creation of an expanded cardiac ablation lesion set during a minimally invasive off-pump procedure. Additionally, the first patient
The allowance of this patent comes shortly after one of Lipoxen’s cornerstone ImuXen patents, which covers the encapsulation of DNA inside a liposome, was allowed in the US.
The milestone payment extends the exclusive use of Elast-Eon 2 in the field of cardiac pacing, ICD (implantable cardiac defibrillator) and cardiac monitoring leads into perpetuity. One further
This Phase I dose-finding study provided clear evidence of the effectiveness of Ardana’s cream in the transdermal delivery of testosterone in females. The double-blind, randomised, placebo-controlled study involved
As part of the optimization phase of development, AGI completed a number of studies in healthy human volunteers. These studies characterized the drug release profile, the pharmacokinetics of